AnaptysBio, Inc.

Home » AnaptysBio, Inc.

Secondary

AnaptysBio, Inc.

They are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation

Symbol

ANAB

Last Closing Price
$69.94

Shares
3,000,000

Effective Date
October 13, 2017

Underwriters
Credit Suisse, Jefferies, Stifel

To view the prospectus for AnaptysBio, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253